Bristol-Myers Squibb Co (BMY)
55.45
+1.13
(+2.08%)
USD |
NYSE |
Nov 04, 16:00
55.30
-0.15
(-0.27%)
Pre-Market: 05:58
Bristol-Myers Squibb Research and Development Expense (Annual): 9.299B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.299B |
| December 31, 2022 | 9.509B |
| December 31, 2021 | 10.20B |
| December 31, 2020 | 11.14B |
| December 31, 2019 | 6.148B |
| December 31, 2018 | 6.332B |
| December 31, 2017 | 6.468B |
| December 31, 2016 | 5.012B |
| December 31, 2015 | 5.92B |
| December 31, 2014 | 4.534B |
| December 31, 2013 | 3.731B |
| December 31, 2012 | 3.904B |
| December 31, 2011 | 3.839B |
| December 31, 2010 | 3.566B |
| December 31, 2009 | 3.647B |
| Date | Value |
|---|---|
| December 31, 2008 | 3.512B |
| December 31, 2007 | 3.282B |
| December 31, 2006 | 2.991B |
| December 31, 2005 | 2.678B |
| December 31, 2004 | 2.50B |
| December 31, 2003 | 2.279B |
| December 31, 2002 | 2.206B |
| December 31, 2001 | 2.183B |
| December 31, 2000 | 1.939B |
| December 31, 1999 | 1.759B |
| December 31, 1998 | 1.506B |
| December 31, 1997 | 1.385B |
| December 31, 1996 | 1.276B |
| December 31, 1995 | 1.199B |
| December 31, 1994 | 1.108B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
6.148B
Minimum
2019
11.14B
Maximum
2020
9.259B
Average
9.509B
Median
2022
Research and Development Expense (Annual) Benchmarks
| Amgen Inc | 4.784B |
| Johnson & Johnson | 15.08B |
| Eli Lilly and Co | 9.313B |
| Merck & Co Inc | 30.53B |
| Pfizer Inc | 10.68B |